Two years ago, I almost died from a brain aneurysm. I was lucky to survive. Half the people who have one die instantly. I’m Kim Lavine, Founder and CEO of Hypersence. We're pioneering the future of enhanced cognitive performance for millions around the world with our patent pending MemorySPEX. Don’t just take my word for it. We won Stanford's "Chairman's Choice" award, competing with startups from around the world. Now this same technology I’ve been pioneering, offers me and millions of others real hope to not only regain the life I had, but to achieve dreams of a better life!
I’m a successful entrepreneur with a track record of selling bestselling products into America’s top retailers. I not only did it, I wrote the critically acclaimed bestselling book on how to do it, MOMMY MILLIONAIRE, to help others do it, too. As the go-to expert on inspirational business advice, I’ve touched and inspired millions through appearances on the Today Show, Rachel Ray, Oprah, CNN, CNBC, and features in USA TODAY, INC, FORBES and BUSINESS WEEK, to name a few.
Declining brain health has become a global epidemic since Covid. As a result, millions are suffering from reduced mental function, poor sleep, and depression.
The only solution for these problems until now has been brain health supplements, which have no independent clinical proof they work. Despite this, brain health supplements are a $14B annual market in the U.S. alone. Can you believe, popular supplements like Prevagen and Neuriva aren’t required by the FDA to prove they work and are totally unregulated? There has got to be a new and better way to fill this exploding consumer need!
That new and better way is MemorySPEX. Our MemorySPEX are safe, non-invasive wearable tech that improves brain function more effectively and at less cost than unproven supplements. The pandemic has only fueled the demand, creating a new exploding market opportunity for brain health wearables, projected to grow 13.6% annually to $895B in 2032. We plan on going to market as an FDA “General Wellness” product, then filing as a predicate device for the treatment of Alzheimer’s on the back of Cognito Therapeutics, who has raised more than $150M to date.
NASA developed strobe science over twenty years ago to treat space sickness in astronauts returning from MIR. Since then, strobe science has been proven in clinical trials by MIT and Georgia Tech to successfully treat Alzheimer’s.
How does it work? Using only ambient light, MemorySPEX use liquid crystal lenses to deliver 40 hertz of gamma oscillations to the hippocampus and visual cortex, clearing harmful plaque and increasing blood flow, improving cognitive function up to 50%. MemorySPEX are so safe and noninvasive, they are classified as an unregulated General Wellness device by the FDA.
Now we’re making this same technology available to consumers to help people gain competitive advantage at work and at school by supercharging the brain. Our consumer-focused MemorySPEX have an MSRP of $300 and a $15 per month subscription fee, for an average cost of $20 per month, less than expensive and unproven supplements, which cost up to $60 per month.
We’re launching MemorySPEX into the retail consumer marketplace for Holiday 2025! Get on our wait list now!
